A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)

NCT06112678 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Dyslipidemias

Interventions

DRUG: CKD-348(6)
DRUG: CKD-828, D097, D337

Sponsor

Chong Kun Dang Pharmaceutical